
Public Affairs – fostering knowledge transfer between industry and public stakeholders
Our public affairs team aspires to be a leader in responsibility and transparency in the public policy process regarding medicinal cannabis and the cannabis legalization for adult-use.
We are committed to open and transparent discussions that advance the discourse on facts, create a safe and better future for our partners, customers and patients in order to promote trust in the European cannabis industry.
We are proud member of key associations within the cannabis industry, furthering our commitment to excellence and collaboration. As a board member (“Vorstandsmitglied”) of the BPC (Federal Association of Pharmaceutical Cannabinoid Companies), we actively contribute to shaping the voice of pharmaceutical cannabinoid companies in Germany. Furthermore, as a supporting member (“Fördermitglied”) of the VCA (Association of Cannabis Supplying Pharmacies e.V.), we are at the forefront of ensuring quality cannabis care through pharmacies. These partnerships underscore our dedication to leading the industry forward with integrity and expertise.
In addition to our focus on ethical business practices, we prioritize compliance with all relevant laws and regulations in the industry, including registering our lobbying activities and working in accordance with state code of conduct.
Find our latest publications and political letters here.
Press contact
Press
notices
Keep up to date with the latest news from Cansativa – from product launches and successes to our latest positions on current developments.
25. September 2024
Thanks to Cansativa: Cookies products are now available in Germany!
"Yes, we can Cannabizz" – Berner is coming to Germany on November 14th.
11. June 2024
Cansativa and Cookies team up to bring Cookies products into the German medical cannabis market.
Cansativa Group will exclusively distribute Cookies-branded medical cannabis products across Germany starting 1st of August 2024
30. October 2023
Cansativa and Cronos Group Inc. launch leading medical cannabis brand PEACE NATURALS® in Germany
Cansativa will import, distribute, and market Cronos brand PEACE NATURALS® Frankfurt am Main, 30th of October 2023
Company presentation
to download

CP 2025
PDF-File (3 MB)
Read
our cannabis
Briefing.
Stay up to date on the latest developments in medical cannabis and the legalization process for adult recreational use.
10. July 2025
Medical Cannabis in Europe: Latest Developments and Germany’s Role in 2025
Medical cannabis is creating waves across Europe—from regulatory advances to controversial setbacks. We have summarized the latest developments from…
27. June 2025
Cansativa Expert Dialogue: Antonia Menzel (BPC) on the Role of Lobbying in the Cannabis Industry
In today's edition of the Cannabis Briefing, we speak with Antonia Menzel, who has been the Chairwoman of the Federal Association of Pharmaceutical…
12. June 2025
Framing Cannabis 2025 – Medicine vs. Recreation at the Mary Jane Expo June 2025
Every year, the Mary Jane Expo in Berlin draws cannabis enthusiasts from all over Europe. From June 19 to 22, 2025, Europe’s largest cannabis trade…
22. May 2025
Cannabis & New Faces in Health Policy: Who’s Leading the Charge?
Germany’s new federal government is in place, ministries and committees have been staffed, and now the question is: which way will the country’s…
9. May 2025
Medical Cannabis in the Spotlight: Evidence & Emerging Research
Medical cannabis is already an evidence-based therapy firmly established for conditions such as chronic pain and spasticity. Of course, additional…
17. April 2025
Europe Moves Ahead – How Switzerland and the Netherlands are Leading on Cannabis Regulation
As Germany’s new federal government continues to organize itself, it's worth looking across the border. Elsewhere in Europe, things are moving — not…
4. April 2025
One Year After the Cannabis Law Reform: A Status Check
A year ago, Germany’s new cannabis law came into effect—more than just a so-called “legalization.” It marked the decriminalization of recreational…
24. March 2025
Cannabis and Chronic Pain: Insights from the 2025 Pain and Palliative Care Conference
Last week, the German Pain and Palliative Care Days 2025 took place in Frankfurt. Among the numerous lectures and workshops, the use of cannabinoids…
6. March 2025
The Endocannabinoid System – A Key to Women’s Health?
The Endocannabinoid System (ECS) is one of the most fascinating yet least understood systems in the human body. It regulates numerous physiological…
27. February 2025
From Berlin to Las Vegas – The Top Cannabis Events of 2025
Which cannabis events should you not miss in 2025? From ICBC Berlin and Spannabis to MJBizCon in Las Vegas – get an overview of the most important…
Position papers
& Publications
Our position papers address many of the most important issues in our business area. They transparently explain our company position and current assessment on specific topics
Q4 2022 | Position paper
PDF file (188 KB)
Known from
Explore Our Cannabis Briefing
Stay ahead with the latest insights in medical cannabis, political decisions, industry news, and research advances.
Stay informed!
Our newsletter is designed to keep you informed and ahead in the rapidly evolving world of medical cannabis. The Cannabis Briefing is your essential resource for the latest research findings, regulatory updates, market trends, and advocacy efforts shaping the future of cannabis.